Archive - March 2018
FDA grants BMS priority review for colorectal cancer combo
GSK buys joint consumer health stake from Novartis for $13 billion
GSK buys Novartis out of consumer health JV after ditching Pfizer bid
Another Tecentriq win for Roche as Avastin combo boosts survival
Takeda’s Alofisel becomes Europe’s first allogeneic stem cell therapy
NHS financial state remains ‘perilous’, concludes PAC
Hospitals failing to test for Lynch syndrome
Ablynx’ vobarilizumab fails in lupus trial